AEGIRBIO AB |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.597 SEK | +2.93% |
|
-0.50% | -48.97% |
| 05-17 | AegirBio AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 04-19 | AegirBio Unit Begins Arbitration Proceedings vs Salofa for Breach of Contract | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Advanced Medical Equipment & Technology
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 1.7M | - | - | - | - | - | |
| 219B | ||||||
| 192B | ||||||
| 142B | ||||||
| 111B | ||||||
| 65.32B |
- Stock Market
- Equities
- AEGIR Stock
- Charts AegirBio AB
- Sector Chart
